← Back to Search

Diagnostic Arthroscopy using the Arthrex NanoScope for Wrist Arthritis

N/A
Waitlist Available
Led By Nader Paksima
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willingness to participate in the study
Wrist pathology based on clinical examination/imaging studies undergoing wrist arthroscopy for further evaluation/treatment.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights

Study Summary

This trial is testing whether the Arthrex NanoScope is better than conventional arthroscopic instruments at diagnosing wrist problems. It will enroll patients who are already scheduled for an arthroscopic procedure and compare the two types of instruments under standard conditions.

Eligible Conditions
  • Wrist Arthritis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are willing to take part in the study.
Select...
You have a wrist problem that needs to be looked at more closely with a procedure called wrist arthroscopy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Surgeon-Rated Midcarpal Visualization With Arthrex Nanoscope
Surgeon-Rated Midcarpal Visualization With Conventional Instrument
Surgeon-Rated Radiocarpal Visualization With Arthrex Nanoscope
+1 more
Secondary outcome measures
Surgeon-rated Confidence in Arthrex NanoScope Diagnosis
Surgeon-rated Confidence in Conventional Instrument Diagnosis
Surgeon-rated Ease of Use of Arthrex NanoScope
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental CohortExperimental Treatment2 Interventions
Patients with clinically diagnosed wrist pathology undergoing wrist arthroscopy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diagnostic Arthroscopy using the Arthrex NanoScope
2020
N/A
~20
Diagnostic Arthroscopy using standard arthroscopic instruments
2020
N/A
~20

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,356 Previous Clinical Trials
816,515 Total Patients Enrolled
Nader PaksimaPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
23 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being observed in this clinical experiment?

"Affirmative. According to clinicaltrials.gov, this research effort is still recruiting volunteer patients after being posted on October 10th 2020 and last updated on August 8th 2022. The trial requires 34 volunteers from one site in particular."

Answered by AI

Is there still an opportunity for participants to join this experiment?

"The trial, which was created on October 10th 2020, is open to participants and has been regularly updated until August 8th 2022. This can be confirmed via clinicaltrials.gov."

Answered by AI
~5 spots leftby Mar 2025